- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Papers: 27 May 2023 - 2 Jun 2023
RESEARCH TYPE:
Basic Science
Animal Studies, In Vitro Studies, Neurobiology, Pharmacology/Drug Development
PAIN TYPE:
Arthritis, Inflammation/Inflammatory
2023
Drug Des Devel Ther
17
Osteoarthritis (OA) is a common chronic joint disease characterized by articular cartilage degeneration. OA usually manifests as joint pain, limited mobility, and joint effusion. Currently, the primary OA treatment is non-steroidal anti-inflammatory drugs (NSAIDs). Although they can alleviate the disease’s clinical symptoms and signs, the drugs have some side effects. Selenium nanoparticles (SeNPs) may be an alternative to relieve OA symptoms.